KURA Kura Oncology, Inc.
Healthcare$11.25+1.08%ClosedMarket Cap: $998.7M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$19.33
Target (Median)
$20.00
Target Range
$15.00 - $23.00
Upside from current price: 71.8%
Rating Distribution
2 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-24 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-13 | UBS | maintain | Buy | Buy |
| 2026-03-06 | Wedbush | maintain | Outperform | Outperform |
| 2026-01-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-13 | Leerink Partners | maintain | Outperform | Outperform |
| 2025-11-24 | Barclays | maintain | Overweight | Overweight |
| 2025-11-14 | UBS | maintain | Buy | Buy |
| 2025-11-14 | Wedbush | maintain | Outperform | Outperform |
| 2025-10-20 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-20 | JMP Securities | maintain | Market Outperform | Market Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.64 | $214.3M | 9 |
| Sun Dec 31 | $-2.00 | $297.8M | 10 |
| Mon Dec 31 | $-0.24 | $522.5M | 4 |
| Tue Dec 31 | $2.45 | $934.9M | 4 |